Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OH2 Oncolytic Virus for Locally Advanced or Metastatic Bladder Cancer
CTR20220192Phase 2Terminated
- Sponsor
- Wuhan Binhui Biopharmaceutical Co., Ltd.
- Start
- Feb 2022
- Modality
- Oncolytic Viruses → Oncolytic Therapeutics, Vaccines & Immunotherapeutics, Gene Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of OH2 in bladder cancer, sponsored by Wuhan Binhui Biopharmaceutical Co., Ltd.. Started Feb 2022; status: terminated.
02
Drugs
OH2
03
Conditions
bladder cancer
Beyond the preview
Go deeper on CTR20220192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220192.